Literature DB >> 2856547

Peripheral benzodiazepine binding sites in human gliomas evaluated with positron emission tomography.

M Bergström1, M Mosskin, K Ericson, E Ehrin, J O Thorell, H von Holst, G Norén, A Persson, C Halldin, S Stone-Elander.   

Abstract

A specific ligand for peripheral type benzodiazepine receptors, Ro5-4864, was synthesised and labelled with 11C for use in positron emission tomography (PET). Four patients with suspected glioma, two patients with high grade astrocytoma and two with low grade astrocytoma, as well as one patient with meningioma were examined with PET after the administration of 200 MBq 11C-Ro5-4864. The images as well as kinetic analyses revealed lower uptake of the ligand in tumor as compared with cortical tissue. Markedly elevated uptake in the thalamus suggests a functional role of the ligand.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2856547

Source DB:  PubMed          Journal:  Acta Radiol Suppl        ISSN: 0365-5954


  4 in total

Review 1.  Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers.

Authors:  Fabien Chauveau; Hervé Boutin; Nadja Van Camp; Frédéric Dollé; Bertrand Tavitian
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-10-01       Impact factor: 9.236

Review 2.  TSPO expression in brain tumours: is TSPO a target for brain tumour imaging?

Authors:  Federico Roncaroli; Zhangjie Su; Karl Herholz; Alexander Gerhard; Federico E Turkheimer
Journal:  Clin Transl Imaging       Date:  2016-03-22

Review 3.  Have (R)-[11C]PK11195 challengers fulfilled the promise? A scoping review of clinical TSPO PET studies.

Authors:  Fabien Chauveau; Guillaume Becker; Hervé Boutin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-08-13       Impact factor: 9.236

Review 4.  TSPO imaging in animal models of brain diseases.

Authors:  Nadja Van Camp; Sonia Lavisse; Pauline Roost; Francesco Gubinelli; Ansel Hillmer; Hervé Boutin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-07-10       Impact factor: 9.236

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.